
Results
4
Most Popular Stocks on the market
4 companies
AFT Pharmaceuticals
Market Cap: NZ$367.0m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$3.50
7D
-1.4%
1Y
33.1%
Pacific Edge
Market Cap: NZ$173.8m
A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.
PEB
NZ$0.17
7D
-3.4%
1Y
69.0%
BLIS Technologies
Market Cap: NZ$21.7m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.
BLT
NZ$0.017
7D
6.3%
1Y
13.3%
Rua Bioscience
Market Cap: NZ$10.1m
Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.
RUA
NZ$0.029
7D
-6.5%
1Y
-9.4%